2C-T-2

2C-T-2_2DACS.svg

2C-T-2_anim.gif

2ct2_Research_Chemical.jpg

2C-T-2 is a psychedelic phenethylamine of the 2C family. It was first synthesized by Alexander Shulgin and described in his book PiHKAL (Phenethylamines I Have Known And Loved). The full chemical name of 2C-T-2 is 2,5-dimethoxy-4-ethylthiophenethylamine.

Chemistry

2C-T-2 belongs to the class of compounds known as phenethylamines, which are characterized by a phenyl ring bound to an amino group through an ethyl chain. The structure of 2C-T-2 includes methoxy groups at the 2 and 5 positions of the phenyl ring and an ethylthio group at the 4 position. Its chemical formula is C_12H_19NO_2S.

Pharmacology

2C-T-2 acts as a serotonin receptor agonist, primarily affecting the 5-HT2A receptor. This interaction is responsible for its psychedelic effects, which can include altered perception, mood, and cognition. The onset of effects typically occurs within 1 to 2 hours after ingestion, with the duration lasting between 6 to 10 hours.

Effects

The effects of 2C-T-2 are similar to those of other psychedelics such as LSD and psilocybin. Users report visual and auditory hallucinations, changes in thought patterns, and an altered sense of time. Some users also experience physical effects such as nausea, muscle tension, and increased heart rate.

Legal Status

The legal status of 2C-T-2 varies by country. In the United States, it is classified as a Schedule I controlled substance under the Controlled Substances Act, making it illegal to manufacture, buy, possess, or distribute without a DEA license. In other countries, its legal status may differ.

Related Compounds

2C-T-2 is part of the larger 2C family of psychedelics, which includes compounds such as 2C-B, 2C-I, and 2C-E. These compounds share a common phenethylamine backbone but differ in their substituent groups, leading to variations in their pharmacological effects and potency.

See Also

• 2C-B
• 2C-I
• 2C-E
• PiHKAL
• Alexander Shulgin
• Phenethylamine

External Links

This psychedelic-related article is a stub. You can help WikiMD by expanding it.